JP2007055903A - 眼血管血流障害改善剤 - Google Patents
眼血管血流障害改善剤 Download PDFInfo
- Publication number
- JP2007055903A JP2007055903A JP2005239841A JP2005239841A JP2007055903A JP 2007055903 A JP2007055903 A JP 2007055903A JP 2005239841 A JP2005239841 A JP 2005239841A JP 2005239841 A JP2005239841 A JP 2005239841A JP 2007055903 A JP2007055903 A JP 2007055903A
- Authority
- JP
- Japan
- Prior art keywords
- blood flow
- ocular
- anthocyanin
- agent according
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
【解決手段】 アントシアニン、特にカシスアントシアニンを有効成分として含有することを特徴とする眼血管血流障害改善剤。
【選択図】 なし
Description
上記眼血管血流障害改善剤は、医薬品又は食品に用いることができる。
本発明は、アントシアニンの用途に係るものであり、アントシアニン、特にカシスアントシアニンが眼血管血流を正常化することを利用するものである。従って、アントシアニンは、眼血管血流障害改善剤において使用することができる。また、上記性質のため、アントシアニンは、眼血管血流障害に関連する疾患又は障害、特に緑内障の予防又は治療に有用である。
下記の処方に従い、アントシアニン含有ソフトカプセルを調製した。アントシアニンは、明治カシスポリフェノール20(明治製菓社製、カシスアントシアニン含量20.5%(うちD3G 2.05%,D3R 9.72%,C3G 0.86%,C3R 7.87%))を用い、ソフトカプセル一粒あたりの内容液が、明治カシスポリフェノール20を120mg(アントシアニンとして25mg)、乳化剤36mg、小麦胚芽油144mgとなるように混合し、ゼラチン皮膜のソフトカプセルを調製した。
Claims (11)
- アントシアニンを有効成分として含有することを特徴とする眼血管血流障害改善剤。
- アントシアニンがカシスアントシアニンである、請求項1記載の眼血管血流障害改善剤。
- 経口投与製剤の形態である、請求項1又は2記載の眼血管血流障害改善剤。
- 眼血管が視神経乳頭の血管である、請求項1〜3のいずれか1項に記載の眼血管血流障害改善剤。
- 医薬品又は食品に用いられる、請求項1〜4のいずれか1項に記載の眼血管血流障害改善剤。
- アントシアニンを有効成分として含有することを特徴とする眼血管血流障害に関連する疾患又は障害の治療剤又は予防剤。
- アントシアニンがカシスアントシアニンである、請求項6記載の治療剤又は予防剤。
- 経口投与製剤の形態である、請求項6又は7記載の治療剤又は予防剤。
- 眼血管血流障害に関連する疾患又は障害が、緑内障、網膜色素変性症、黄斑変性症、虚血性視神経症、虹彩毛様体炎、網膜動脈閉塞症、網膜静脈閉塞症、糖尿病性網膜症、網膜病変に続発する脈絡膜疾患及び全身疾患を伴う網膜脈絡膜疾患からなる群より選択される、請求項6〜8のいずれか1項に記載の治療剤又は予防剤。
- 眼血管血流障害に関連する疾患又は障害が正常眼圧緑内障である、請求項6〜9のいずれか1項に記載の治療剤又は予防剤。
- 請求項1〜5のいずれか1項に記載の眼血管血流障害改善剤の有効量を被験体に投与する又は被験体に摂取させることを含む、眼血管血流障害の改善方法。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005239841A JP4873904B2 (ja) | 2005-08-22 | 2005-08-22 | 眼血管血流障害改善剤 |
PCT/JP2006/316346 WO2007023774A1 (ja) | 2005-08-22 | 2006-08-22 | 眼血管血流障害改善剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005239841A JP4873904B2 (ja) | 2005-08-22 | 2005-08-22 | 眼血管血流障害改善剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007055903A true JP2007055903A (ja) | 2007-03-08 |
JP4873904B2 JP4873904B2 (ja) | 2012-02-08 |
Family
ID=37771519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005239841A Active JP4873904B2 (ja) | 2005-08-22 | 2005-08-22 | 眼血管血流障害改善剤 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP4873904B2 (ja) |
WO (1) | WO2007023774A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008301752A (ja) * | 2007-06-07 | 2008-12-18 | Pola Chem Ind Inc | 疲れ目用の食品及びその製造法 |
JP2013522188A (ja) * | 2010-03-10 | 2013-06-13 | チョウン、ス−ヨン | クロマメノキ抽出物またはクロマメノキ分画物を有効成分として含む黄斑変性症の治療、予防または改善用組成物 |
JP2013135658A (ja) * | 2011-11-28 | 2013-07-11 | Fancl Corp | アントシアニン安定化組成物 |
JP2013163669A (ja) * | 2012-01-12 | 2013-08-22 | Oriza Yuka Kk | 可視光誘発網膜障害抑制剤及びそれを用いた眼疾患予防・治療剤 |
CN103908627A (zh) * | 2013-01-03 | 2014-07-09 | 杨丽敏 | 治疗视网膜中央静脉阻塞的中药制剂 |
JP2019531296A (ja) * | 2016-09-29 | 2019-10-31 | 彦臣生技藥品股▲ふん▼有限公司NatureWise Biotech& Medicals Corporation | 眼疾患の処置方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8883230B2 (en) * | 2008-02-25 | 2014-11-11 | National Yang-Ming University | Use of black soybean for treating ophthalmic diseases |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6011416A (ja) * | 1976-09-08 | 1985-01-21 | インベルニ・デラ・ベツフア・エス・ピ−・エ− | アントシアニジンを有効成分とする医薬 |
JPH0381220A (ja) * | 1989-07-28 | 1991-04-05 | Idb Holding Spa | 眼病用製薬組成物 |
WO2001001798A1 (fr) * | 1999-07-02 | 2001-01-11 | Meiji Seika Kaisha, Ltd. | Composition pour aliments, procede de production de cette composition et aliments et boissons fonctionnels contenant cette composition |
JP2004262878A (ja) * | 2003-03-04 | 2004-09-24 | Meiji Seika Kaisha Ltd | 血流改善作用を有する組成物および飲食品 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005077176A1 (en) * | 2004-02-11 | 2005-08-25 | The Trustees Of Columbia University In The City Of New York | Anthocyanin compounds and methods of use thereof |
-
2005
- 2005-08-22 JP JP2005239841A patent/JP4873904B2/ja active Active
-
2006
- 2006-08-22 WO PCT/JP2006/316346 patent/WO2007023774A1/ja active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6011416A (ja) * | 1976-09-08 | 1985-01-21 | インベルニ・デラ・ベツフア・エス・ピ−・エ− | アントシアニジンを有効成分とする医薬 |
JPH0381220A (ja) * | 1989-07-28 | 1991-04-05 | Idb Holding Spa | 眼病用製薬組成物 |
WO2001001798A1 (fr) * | 1999-07-02 | 2001-01-11 | Meiji Seika Kaisha, Ltd. | Composition pour aliments, procede de production de cette composition et aliments et boissons fonctionnels contenant cette composition |
JP2004262878A (ja) * | 2003-03-04 | 2004-09-24 | Meiji Seika Kaisha Ltd | 血流改善作用を有する組成物および飲食品 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008301752A (ja) * | 2007-06-07 | 2008-12-18 | Pola Chem Ind Inc | 疲れ目用の食品及びその製造法 |
JP2013522188A (ja) * | 2010-03-10 | 2013-06-13 | チョウン、ス−ヨン | クロマメノキ抽出物またはクロマメノキ分画物を有効成分として含む黄斑変性症の治療、予防または改善用組成物 |
JP2013135658A (ja) * | 2011-11-28 | 2013-07-11 | Fancl Corp | アントシアニン安定化組成物 |
JP2013163669A (ja) * | 2012-01-12 | 2013-08-22 | Oriza Yuka Kk | 可視光誘発網膜障害抑制剤及びそれを用いた眼疾患予防・治療剤 |
CN103908627A (zh) * | 2013-01-03 | 2014-07-09 | 杨丽敏 | 治疗视网膜中央静脉阻塞的中药制剂 |
JP2019531296A (ja) * | 2016-09-29 | 2019-10-31 | 彦臣生技藥品股▲ふん▼有限公司NatureWise Biotech& Medicals Corporation | 眼疾患の処置方法 |
JP2021138710A (ja) * | 2016-09-29 | 2021-09-16 | 彦臣生技藥品股▲ふん▼有限公司NatureWise Biotech & Medicals Corporation | 眼疾患の処置方法 |
Also Published As
Publication number | Publication date |
---|---|
JP4873904B2 (ja) | 2012-02-08 |
WO2007023774A1 (ja) | 2007-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7121056B2 (ja) | フラボノイド組成物及び使用方法 | |
EP4260853A1 (en) | Composition comprising (7s)-(+)-cyclopentyl carbarmic acid, 8,8-dimethyl-2-oxo-6,7-dihydro-2h,8h-pyrano[3,2-g]chromen-7-yl-ester as active ingredient for prevention, alleviation, or treatment of eye disease | |
JP4873904B2 (ja) | 眼血管血流障害改善剤 | |
JP2009502958A (ja) | ストレスの治療または管理の方法 | |
WO2005074962A1 (ja) | 筋張力増強剤 | |
US20090297618A1 (en) | Composition beneficial for visuognosis persistence and use thereof | |
US20090175973A1 (en) | Coffee cherry compositions and methods for their use in the treatment of diabetes and diabetes related disorders | |
JP2020528898A (ja) | 医薬品、サプリメント及び摂取物質のバイオアベイラビリティを増進する組成物 | |
CN104302302B (zh) | 包含作为活性成分的蓝靛果忍冬的果实提取物用于预防或改善缺血性脑血管病的药物组合物或保健食品 | |
JP6445686B2 (ja) | ジペノサイド75の抗糖尿病効果 | |
WO2005074961A1 (ja) | 体脂肪調整剤 | |
KR20050078663A (ko) | 혈류 개선 식품 | |
KR102009966B1 (ko) | 굴피나무 추출물을 유효성분으로 함유하는 뇌졸중 치료, 개선 또는 예방용 조성물 | |
US11185553B2 (en) | Pharmaceutical composition for preventing or treating ischemic-reperfusion injury comprising bile acids | |
KR20180138109A (ko) | 망막 질환 예방, 개선, 완화 또는 치료용 조성물 | |
KR101660834B1 (ko) | 지페노사이드 75의 항당뇨 효과 | |
US20090318552A1 (en) | Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizo dor treating or preventing diabetes mellitus and the use thereof | |
JP6923922B2 (ja) | ジンセノサイドf2を有効成分として含む肝がんの予防または治療用組成物 | |
JP2009107945A (ja) | 視神経障害抑制剤及びそれを含有する飲食品 | |
KR101835227B1 (ko) | 서목태 추출물을 포함하는 안질환 예방 또는 치료용 조성물 | |
JPWO2019168185A1 (ja) | 後眼部異常の予防及び/又はリスク軽減用食品組成物 | |
JP6093100B2 (ja) | 赤血球機能向上剤 | |
KR101536231B1 (ko) | 엘루테로사이드 e를 포함하는 인슐린 저항성 또는 인슐린 저항성 관련 질환의 예방 또는 치료용 조성물 | |
JP2021500382A (ja) | 非アルコール性脂肪肝疾患の予防または改善用組成物 | |
KR102380295B1 (ko) | 귀리 추출물을 포함하는 근감소증 예방, 개선 또는 치료용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080616 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20110419 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20110621 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110816 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111013 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111101 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111122 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141202 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4873904 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |